ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
Dow Jones
43.297,03
0,91%
Euro vs US Dollar
1,04255
0,21%
Bitcoin
98.350,74
-0,33%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Neuronetics Inc (STIM)

  7. Neuronetics Inc (STIM) News

STIM

Neuronetics (STIM)

Neuronetics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:STIM
DatumZeitQuelleÜberschriftSymbolFirma
19/12/202423h54Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
19/12/202423h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
19/12/202423h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
18/12/202422h30GlobeNewswire Inc.Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:STIMNeuronetics Inc
18/12/202403h15Edgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:STIMNeuronetics Inc
16/12/202422h30GlobeNewswire Inc.Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:STIMNeuronetics Inc
12/12/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
12/12/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
12/12/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
10/12/202422h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
10/12/202416h00GlobeNewswire Inc.Neuronetics and Greenbrook TMS Announce Closing of TransactionNASDAQ:STIMNeuronetics Inc
20/11/202414h30GlobeNewswire Inc.Neuronetics to Present at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:STIMNeuronetics Inc
14/11/202420h32Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:STIMNeuronetics Inc
14/11/202417h32Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:STIMNeuronetics Inc
14/11/202417h17Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:STIMNeuronetics Inc
13/11/202412h44Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:STIMNeuronetics Inc
13/11/202400h45GlobeNewswire Inc.CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating ResultsNASDAQ:STIMNeuronetics Inc
12/11/202422h30GlobeNewswire Inc.Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:STIMNeuronetics Inc
12/11/202413h31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:STIMNeuronetics Inc
12/11/202413h10GlobeNewswire Inc.Neuronetics Reports Record Third Quarter 2024 Financial and Operating ResultsNASDAQ:STIMNeuronetics Inc
12/11/202413h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
12/11/202413h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
12/11/202413h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
01/11/202422h20Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:STIMNeuronetics Inc
01/11/202422h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
29/10/202421h30GlobeNewswire Inc.Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference CallNASDAQ:STIMNeuronetics Inc
14/10/202414h31GlobeNewswire Inc.NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with DepressionNASDAQ:STIMNeuronetics Inc
10/10/202423h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
10/10/202423h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
09/10/202422h30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:STIMNeuronetics Inc
 Showing the most relevant articles for your search:NASDAQ:STIM

Kürzlich von Ihnen besucht

LSE
BY82
Natixis St. 30
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten